Mineralocorticoid receptor: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size=' | <StructureSection load='' size='350' side='right' caption='Glycosylated human mineralocorticoid receptor ligand-binding domain complex with aldosterone, glycerol and sulfate (PDB entry [[2aa2]])' scene='78/781019/Cv/1'> | ||
| Line 38: | Line 38: | ||
**[[2ab2]], [[3vhu]], [[2oax]] – hMR LBD (mutant) + spironolactone <br /> | **[[2ab2]], [[3vhu]], [[2oax]] – hMR LBD (mutant) + spironolactone <br /> | ||
**[[3wff]], [[3wfg]], [[4pf3]], [[3vhv]], [[5hcv]] – hMR LBD (mutant) + antagonist <br /> | **[[3wff]], [[3wfg]], [[4pf3]], [[3vhv]], [[5hcv]] – hMR LBD (mutant) + antagonist <br /> | ||
**[[2a3i]] – hMR LBD (mutant) + NCOA1 peptide <br /> | **[[5mwy]] – hMR LBD + NCOA1 peptide <br /> | ||
**[[2a3i]], [[5mwp]] – hMR LBD (mutant) + NCOA1 peptide <br /> | |||
**[[5l7e]], [[5l7g]], [[5l7h]], [[4uda]], [[4udb]] – hMR LBD + NCOA1 peptide + antagonist<br /> | **[[5l7e]], [[5l7g]], [[5l7h]], [[4uda]], [[4udb]] – hMR LBD + NCOA1 peptide + antagonist<br /> | ||
}} | }} | ||